{
    "Trade/Device Name(s)": [
        "hemochroma PLUS System",
        "hemochroma PLUS Controls",
        "hemochroma PLUS Analyzer",
        "hemochroma PLUS Microcuvettes",
        "hemochroma PLUS ID Chip",
        "hemochroma PLUS Optical System Check Microcuvette"
    ],
    "Submitter Information": "Boditech Med, Inc.",
    "510(k) Number": "K182298",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061047"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKR",
        "GGM"
    ],
    "Summary Letter Date": "August 22, 2018",
    "Summary Letter Received Date": "August 24, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5620",
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Automated hemoglobin system",
        "Hematology quality control mixture"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole blood (capillary/finger-stick)",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Sodium citrate tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "hemochroma PLUS Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Dual wavelength photo-absorption",
        "Spectrophotometry"
    ],
    "Methodologies": [
        "Photometric determination"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Microcuvette",
        "Control",
        "ID Chip",
        "Optical system check microcuvette"
    ],
    "Document Summary": "FDA 510(k) summary for Boditech Med hemochroma PLUS System for quantitative hemoglobin determination in whole blood using a hand-held analyzer with microcuvettes.",
    "Indications for Use Summary": "Quantitative determination of hemoglobin concentration in non-anticoagulated capillary (finger-stick) whole blood or venous whole blood (K2-EDTA, K3-EDTA, sodium citrate, lithium heparin, or sodium heparin) for point-of-care settings, hospitals, and medical labs; estimation of hematocrit for normal hemoglobin values in patients \u22656 months old; controls for quality assurance; in vitro diagnostic use only.",
    "fda_folder": "Hematology"
}